Recent Updates
Recently added Catalysts
INSP Positive Sentiment

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Monday, December 29, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Inspire Medical Systems, Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. The presentation will highlight the company's innovative solutions for obstructive sleep apnea, including its FDA-approved Inspire therapy. A live webcast will be available, along with a replay for two weeks post-event.
Price reaction · baseline $95.47 (2025-12-26 close) · hit pre-market · clean, no other INSP news in the window
day 0 close · peak
-1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Inspire Medical Systems is presenting at a prestigious healthcare conference.
  • The company focuses on innovative solutions for obstructive sleep apnea.
  • Inspire therapy is FDA and EU MDR approved, indicating regulatory confidence.

Full Press Release Details

MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44thAnnual J.P. Morgan Healthcare Conference on Monday, January 12, 2026.
Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible via a live webcasthere.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website athttps://investors.inspiresleep.com.
About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visitwww.inspiresleep.com.

Investor and Media ContactEzgi YagciVice President, Investor Relationsezgiyagci@inspiresleep.com617-549-2443

Frequently Asked Questions

When will Inspire Medical Systems present?

Inspire Medical Systems will present on January 12, 2026.

What is the focus of Inspire Medical Systems?

The company focuses on solutions for obstructive sleep apnea.

How can I access the presentation?

The presentation will be available via a live webcast.

Is there a replay available after the presentation?

Yes, a replay will be available for two weeks after the event.

ShareAdd on Google
Tags: INSP Viatris Investor Conferences Healthcare Inspire Medical Systems J.P. Morgan Healthcare Conference obstructive sleep apnea FDA approved neurostimulation technology
Last updated: Dec 29, 2025

Biotech snapshot

Cash runway
$415M liquidity · $0M/mo burn
Low dilution risk
Lead asset
Inspire Upper Airway Stimulation SystemPhase 3
Obstructive Sleep Apnea →